The one thing (or one of the things) i liked with this company is it has been around for a few years and has fallen from 60c ish to current levels, and yet in the 6 years that has taken they really havent blown out the register as far as they could have. It appears that up until 08 they still had only 100 million on issue, and it is only in the last two years that the register has doubled and doubled again. If the 2 million can get them to cash sustainability, and from there to some big deals then there is no need for the sgares on issue to ballon much further. Currently a significant milestone payment spread over 500 million shares may still have the power to put a rocket under this. Also seems the earlier big deals are moving into second and third stages so if collaboration continues one would think payments should start to ramp up if The partners actually see something they regard as valuable. Realistically any one of Roche, Pfizer etc could just find one peptide that fits their requirements, and maybe buy the company to stop the other collaborations????
PYC Price at posting:
5.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)